Status:
TERMINATED
Endoscopic Stenting Versus Surgical Bypass for Low Bile Duct Obstruction by Cancer of the Pancreatic Head
Lead Sponsor:
Heidelberg University
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The prognosis of patients with unresectable pancreatic cancer is dismal. Hence, palliation of tumor-associated symptoms, in particular jaundice due to low bile duct obstruction and gastric outlet obst...
Eligibility Criteria
Inclusion
- Age equal or greater than 18 years
- Diagnosis of unresectable cancer of the pancreatic head (after clinical, laboratory, radiological assessment) requiring palliative treatment for biliary obstruction. In unclear cases an exploratory laparotomy will be performed and resectability will be evaluated intraoperatively
- Operability certified by anesthesiologist
- Written informed consent
Exclusion
- Intervention technically/medically not feasible
- Expected lack of compliance
- One treatment option considered to be clearly in favor of the patient
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 16 2017
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00753441
Start Date
February 1 2009
End Date
August 16 2017
Last Update
October 27 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universityhospital Heidelberg
Heidelberg, Germany, 69120